Form 4: KORU Medical Systems Director Acquires Shares in Recent Transaction

Sentiment:

SEC Form 4 Filing


Director Shahriar Matin acquired 3,937 shares of KORU Medical Systems at $3.81 per share on January 3, 2025, increasing his direct holdings to 77,545 shares.

Summary

  • On January 3, 2025, Shahriar Matin, a director of KORU Medical Systems, Inc., acquired 3,937 shares of common stock at a price of $3.81 per share.
  • Following this transaction, Matin directly owns 77,545 shares of KORU Medical Systems.
  • The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

  • A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects relative to its industry peers. This transaction is a routine disclosure and doesn't necessarily indicate a major shift in the company's outlook.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.

Key Dates

DateDescription
01/03/2025Date of transaction: Shahriar Matin acquired 3,937 shares of KORU Medical Systems at $3.81 per share.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.